Vifor Pharma CellCept proven superior to azathioprine in study Pharmaceutical Business Review Vifor Pharma's mycophenolate mofetil (CellCept) has proven its superiority over azathioprine (Imuran) in the maintenance therapy of lupus nephritis, as evident from the Phase 3 study published in the New England Journal of Medicine (NEJM). ... |
